Entering the APAC Region: Opportunities and Challenges for Consultancies

Expanding into the Asia-Pacific (APAC) region presents significant opportunities—and notable challenges—for consultancies. While Europe and the U.S. remain key markets for global expansion, APAC’s rapid economic growth, ageing populations, and rising healthcare demands are creating a compelling case for consultancies to establish a regional presence.

Why APAC Matters

Japan and China are the two most strategically important APAC markets for life sciences after the U.S. and Europe [1]. By 2022, regional healthcare expenditure across APAC was expected to grow by 7% annually, outpacing the U.S. and Europe [2]. For consultancies, this represents a significant opportunity to support BioPharma clients expanding into developing markets, capture strategic growth, and increase competitive advantage.

However, entering APAC is not straightforward. Unlike Europe’s relatively harmonised markets, APAC is highly diverse in healthcare systems, economic maturity, regulatory frameworks, and patient expectations. Emerging and developing markets vary dramatically, requiring consultancies to carefully assess which markets align best with their capabilities and service offerings.

Opportunities in Developed and Developing Markets

Developed APAC markets such as Japan and Australia share similarities with European systems: universal healthcare, government-led reimbursement, and mature patient expectations. The focus here is often on optimising healthcare delivery through technology, managing ageing populations, and treating non-communicable diseases (NCDs).

Developing markets present both scale and growth potential. Large populations, rising affluence, and unmet healthcare needs make these markets attractive, particularly for consultancies that can bring cross-functional expertise. With workforce shortages and increasing NCD prevalence, there is growing demand for consultancies to provide advisory support, outsource skilled teams, and implement innovative healthcare strategies.

With over half of the world’s population residing in APAC, the opportunity is substantial. The region currently accounts for roughly 30% of global pharmaceutical spending and is projected to triple by 2030 [3].

Demographic Drivers of Demand

Ageing populations are transforming healthcare needs across APAC. Japan and China are experiencing a surge in older populations, increasing demand for quality, timely, and sustainable care. Countries with declining workforce levels face pressure on productivity and healthcare delivery, which in turn drives demand for consultancy support in strategic workforce planning and operational efficiency.

Rising non-communicable diseases (NCDs), including cancer, diabetes, and cardiovascular conditions, further increase demand for specialised consulting services. For consultancies with expertise in precision medicine or chronic disease management, APAC represents a strategic opportunity to guide BioPharmas in addressing these high-burden areas.

Digital Transformation as a Competitive Advantage

The APAC region is a hub of digital health innovation. In both emerging and developed markets, digital tools and analytics are transforming healthcare delivery. In China, for example, 94% of healthcare professionals utilise digital apps and platforms to optimise patient outcomes [4].

For consultancies, leveraging digital solutions can:

• Enhance efficiency and collaboration across global, regional, and local teams
• Support smarter market access and reimbursement strategies
• Accelerate product launches and evidence generation
• Provide a competitive edge in offering data-driven insights and digital health expertise

Consultancies that integrate digital capabilities into their APAC strategy can not only unlock market opportunities but also help BioPharmas deliver cost-effective, patient-centric solutions.

Talent: The Key to Success in APAC

Ultimately, consultancies entering APAC must recognise that talent is central to success. Understanding local markets, language, culture, and healthcare policies is critical for executing effective strategies. While skillsets are largely transferable from U.S. and European teams, local knowledge ensures solutions are tailored and impactful.

Deploying experienced consultants in APAC provides dual benefits:

1. Client impact: Teams with both regional and global expertise can navigate market complexity, regulatory requirements, and stakeholder engagement effectively.
2. Professional development: Consultants gain exposure to diverse healthcare systems, emerging challenges, and cross-cultural working environments, enhancing their skillsets and career trajectories.

Investing in talent strategy—through recruitment, training, and knowledge transfer—is essential for consultancies to capitalise on APAC opportunities while mitigating operational and cultural risks.

Conclusion

APAC presents a compelling yet complex growth opportunity for consultancies. The combination of ageing populations, rising NCDs, and rapid digital adoption creates a high-demand market for strategic consulting services. Success in the region depends not only on market insight and digital capability but also on deploying the right talent with local knowledge and global expertise. By aligning market strategy with people strategy, consultancies can expand their presence in APAC while delivering meaningful impact to clients and developing their workforce.